Verrica Pharmaceuticals Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Verrica Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.16M, a 144% decline year-over-year.
  • Verrica Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$7.35M, a 1507% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was -$1.24M, a 61.3% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$3.19M, a 23.5% increase from 2021.
  • Verrica Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was -$4.17M, a 66% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.24M +$1.96M +61.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$3.19M +$981K +23.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$4.17M -$1.66M -66% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$2.51M -$4.39M -234% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $1.87M +$643K +52.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $1.23M +$1.23M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$2K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.